Switzerland / A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
Top Stories
Data / BC Platforms CEO on Data's Transformational Impact for Healthcare Systems & Life Sciences R&D
CEO Tero Silvola introduces BC Platforms’ powerful data and technology platform for personalized medicine and drug development and the ‘infinity loop’ between the interconnected sectors of healthcare and life sciences…
France / Top 10 Pharma Companies
The Top 10 pharma companies in the EUR 28.9 million French pharma market in 2019. Homegrown players Sanofi and…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
APAC / Aligning Combination Product Regulations: A Distant Dream?
Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia…
LatAM & Caribbean / Importance of Reliance to Support Strengthening Regulatory Systems
Writing in the April edition of DIA’s Global Forum magazine, Maria Cristina Mota Pina of Abbvie on behalf of…
In Conversation
Katharina Gasser – Managing Director, Biogen Switzerland
Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication perspective, the increasing importance being given to mental health by the Swiss government, and the reimbursement and market challenges facing Biogen in 2021 and beyond. 2020 saw a lot of innovation, new thinking, and new approaches being developed. Change came…
Latest Reports
Focus on Singapore
HSA: APAC’s Regulatory Gold Standard
As the most important pharma hub in its region, and one of the most important…
Medtech’s Post-COVID Paradigm in APAC
At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech…
APAC: Prestige & HH&L IPO News; Cold Chain Vaccine…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for…
Singapore Pharma Industry Snapshot 2020
Singapore is home to a wide range of biopharmaceutical company headquarters,…
Read more: Singapore >>
Focus on Europe
Switzerland: A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine…
Europe: EMA Medicine Approvals 2020
The full list of medicines recommended for approval by the European Medicines…
Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that…
Read more: Europe >>
Focus on USA
USA: 2 Things the Biden Administration can do Now to Lower…
PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can…
NORD Chief Strategy Officer on Health Equity’s Vital…
With Rare Disease Day coming up on February 28th, one of the leading…
5 US Rare Disease Start-Ups to Watch
Following on from our profile on five of the most promising clinical-stage…
US FDA Drug Approvals 2020
In 2020, the US FDA's Center for Drug Evaluation & Research (CDER) approved…
Read more: USA >>
Focus on China
China: Yangtze River Pharmaceutical Group (YRPG) in Profile
One of the largest domestic pharma companies in China (ranking number one from…
Top 10 Chinese Pharma Companies 2020
The Top 10 Chinese pharma companies for 2020 ranked by overall revenues. Taken…
New Drug Approvals in China 2020
The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals…
Public Insurance Coverage for Rare Disease Patients in…
Kevin Rufang Huang, president and founder of the Chinese Organization for Rare…
Read more: China >>
Focus on Vaccines
Russia Pharma News: Biocad Ramps up Sputnik V Manufacturing;…
The latest news from Russian pharma, including Biocad’s ramping up of Sputnik…
UK Pharma News: Fastest Growing Private Pharmacos; GSK…
The latest UK pharma news, including how new investment in GSK stands to reshape…
German Pharma: Highest Honours for BioNTech Founders;…
A roundup of some of the most important recent news from German pharma,…
Valneva: A COVID-19 Vaccine Success Story for France?
While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed…
Read more: Vaccines >>
Focus on MEA
5 Things to Know about Saudi Arabian Pharma
A rundown of five things to know about the USD 8.2 billion Saudi pharma market,…
MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab…
The latest news from Middle East & North African pharma, including…
5 Saudi Arabian Pharma Companies to Know
Following on from our list of the overall top 10 companies in the Saudi Arabian…
MEA: Iran looks to Cuba for COVID-19 Vaccine; Israel Leads…
The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region,…
Read more: MEA >>
Focus on Switzerland
Building a Health Data Ecosystem in Switzerland
Although Switzerland is ahead of many of its competitors in Europe on levels of…
Ichnos CEO on Glenmark Legacy, Biotech Transformation &…
After an illustrious career in oncology R&D, contributing greatly to the…
Swissmedic New Drug Approvals 2020
Regarded as one of the world’s leading regulatory bodies, Swissmedic stands…
Swiss Pharma: Staying the Course
This article forms part of Healthcare & Life Sciences Review: Switzerland…